Receptor dimers have been proposed as the functional unit responsible for catalytic interaction with G␣␤␥. To investigate whether a G protein-coupled receptor monomer can activate G␣␤␥, we used the retinal photoreceptor rhodopsin and its cognate G protein transducin (G t) to determine the stoichiometry of rhodopsin/Gt binding and the rate of catalyzed nucleotide exchange in G t. Purified rhodopsin was prepared in dodecyl maltoside detergent solution. Rhodopsin was monomeric as concluded from fluorescence resonance energy transfer, copurification studies with fluorescent labeled and unlabeled rhodopsin, size exclusion chromatography, and multiangle laser light scattering. A 1:1 complex between light-activated rhodopsin and G t was found in the elution profiles, and one molecule of GDP was released upon complex formation. Analysis of the speed of catalytic rhodopsin/G t interaction yielded a maximum of Ϸ50 Gt molecules per second and molecule of activated rhodopsin. The bimolecular rate constant is close to the diffusion limit in the diluted system. The results show that the interaction of Gt with an activated rhodopsin monomer is sufficient for fully functional Gt activation. Although the activation rate in solution is at the physically possible limit, the rate in the native membrane is still 10-fold higher. This is likely attributable to the precise orientation of the G protein to the membrane surface, which enables a fast docking process preceding the actual activation step. Whether docking in membranes involves the formation of rhodopsin dimers or oligomers remains to be elucidated. enzyme catalysis ͉ nucleotide exchange ͉ light scattering
G
protein-coupled receptors (GPCRs) constitute the largest group of transmembrane receptors. These seventransmembrane helix proteins are involved in detecting a wide variety of chemical and physical stimuli, ranging from ligand binding to light perception (1) . In their active state, GPCRs catalyze nucleotide exchange in heterotrimeric G proteins (G␣␤␥) and thereby route extracellular signals to distinct intracellular signaling pathways (2) . Rhodopsin is the prototype and eponym of the largest class of GPCRs, the rhodopsinlike GPCRs (class A). Together with its cognate G protein transducin (G t ), it is part of the visual signaling system found on the disk membranes in the outer segment of vertebrate rod photoreceptor cells. Rhodopsin is activated by photon absorption, causing cis-trans isomerization of the chromophore 11-cis-retinal, which is bound covalently to the apoprotein opsin. Optimal photon absorption of photoreceptor cells is ensured by the high density of rhodopsin in the disk membranes [Ͼ25,000 receptors per m 2 (3)]. In disk membranes on mica support, rows of rhodopsin dimers were observed by atomic force microscopy (4) . Different types of dimers also were found in crystal structures of rhodopsin (see ref. 5 and references therein). Such direct structural analysis of a GPCR currently is available only for rhodopsin. However, other GPCRs also were found to associate as dimers and higher-order oligomers in living cells (see, e.g., refs. 6-8), although monomers prevail at low expression levels (9, 10) . Molecular modeling (11) (12) (13) , FRET measurements (14) (15) (16) , and biochemical approaches (5, 17, 18) are consistent with a model in which dimers or higher-order oligomers of rhodopsin, or class A GPCRs in general, constitute the functional unit for G protein activation (19) (20) (21) . Although this paradigm has been questioned (10, 22, 23) , a supramolecular organization of GPCRs indeed may enhance the performance and fidelity with which signals are transferred to the G protein in signal transduction modules (11, 24) . Using a simplified system, namely monomeric rhodopsin in detergent solution, we have tested whether such organization of rhodopsin is necessary for efficient catalytic activation of G t , i.e., nucleotide exchange in the ␣-subunit of G t by interaction with light-activated rhodopsin (R*).
Results

Preparation of Monomeric Rhodopsin in Detergent Solution.
Rhodopsin used in this study was either prepared from bovine disk membranes or expressed as its apoprotein opsin in COS-1 cells and reconstituted with 11-cis-retinal. For solubilization and purification of rhodopsin, we used n-dodecyl-␤-D-maltopyranoside (DDM) detergent and an immunoaffinity procedure, respectively. We found that the obtained rhodopsin was monomeric, as shown by several lines of evidence:
i. No FRET was observed when opsin apoproteins fused to monomeric variants of enhanced cyan fluorescent protein (mECFP) or yellow fluorescent protein (mVenus), respectively, were coexpressed in COS-1 cells, reconstituted with 11-cis-retinal, and copurified in DDM solution. In contrast, a positive FRET control consisting of a purified mVenusmECFP fusion showed FRET (Fig. 1) . Also, when expressed in COS-1 cells, fluorescent opsin fusion proteins in the cell membrane showed FRET (15) , indicating a quaternary structure in these membranes. ii. To verify that our purification protocol yielded monomeric rhodopsin, we performed coexpression and copurification with rhodopsin and the rhodopsin-mVenus fusion protein (Fig. 2) . Using unmodified rhodopsin as a purification handle, it was not possible to copurify rhodopsin-mVenus fusion protein lacking a C-terminal affinity tag, which argues again for rhodopsin monomers in solution.
iii. The immunoaffinity purification protocol then was used to purify native rhodopsin from bovine rod cells. Size exclusion chromatography (SEC) of the purified rhodopsin revealed high homogeneity and purity of the preparation as indicated by the absorption spectrum (Fig. 3A) . iv. Further analysis by SEC in combination with multiangle laser light scattering (MALLS) detection showed that only monomers were present in the main elution peak of dark state rhodopsin (Fig. 3B) . MALLS evaluation of each elution slice (Fig. 3B ) revealed for the central part of the elution peak that protein monomers (experimental mass Ϸ35 kDa; theoretical mass Ϸ39 kDa; Fig. 3B , red circles) are enclosed by a detergent micelle on the scale of Ϸ74 kDa (Fig. 3B , green circles), yielding a rhodopsin-detergent complex of Ϸ110 kDa (Fig. 3B, black circles) . The monomeric nature of rhodopsin remained unaffected after light-activating it directly before the SEC run.
Stoichiometry of Interaction Between Monomeric Rhodopsin and
Transducin. We analyzed the interaction of monomeric rhodopsin with G t by SEC (Fig. 4) . SEC first was performed with inactive dark state rhodopsin mixed with inactive GDP-bound G t (Fig.  4A ). To study the interaction of R* with G t , the mixture of rhodopsin and G t was illuminated with orange light immediately before SEC to produce R*. Interaction between R* and G t was observed as a shift of the elution peak to a lower elution volume attributable to R*⅐G t complex formation (Fig. 4B) . The different absorption maxima of proteins (280 nm) and retinal chromophore (380 nm; as part of R*) allowed us to determine a stoichiometry of 1:1 for R* and G t in the main peak containing the protein complex (see Fig. 4 legend and Materials and Methods for details). The equimolar R*:G t stoichiometry was confirmed further by analysis of GDP release upon R*⅐G t complex formation (Fig. 4C ). The amount of R*⅐G t complex formed is reflected in the area of the elution peak detected at 380 nm (absorption Fig. 1 . FRET experiments. Monomeric cyan or yellow variants of GFP fused to the opsin C terminus (R-mECFP and R-mVenus, respectively) were expressed separately and together in COS-1 cells, reconstituted with 11-cisretinal, and purified. Normalized emission spectra (excitation at 420 nm) are shown for purified R-mECFP (cyan line), copurified R-mECFP/R-mVenus (red line), and a fusion protein consisting of mECFP and mVenus as positive FRET control (green line). The spectra of proteins containing an mVenus moiety were corrected for direct excitation of mVenus by the 420 nm excitation beam as described in Materials and Methods. FRET is reflected in the difference between the corrected spectra (dotted lines) and the spectrum of R-mECFP (cyan line). These difference spectra (broken lines) show that FRET only occurs in the mVenus-mECFP positive FRET control but not in the R-mECFP/RmVenus sample. FRET also was lacking in copurified R-mECFP/R-mVenus after illumination of the sample for 15 s with orange light (data not shown). . The small contribution of mVenus to the absorption at Ϸ516 nm is attributable to the weak affinity of the rho-1D4 antibody for the internal epitope (see C). The results show that fluorescent-protein-tagged rhodopsin lacking the C-terminal epitope tag does not copurify with coexpressed wild-type rhodopsin. Analogously, coexpression of R-mVenus and wild-type rhodopsin lacking the 1D4 epitope yielded spectra very similar to R-mVenus alone (data not shown).
maximum of R*; Fig. 4C ). Analogously, the area of the GDP elution peak detected at 253 nm (absorption maximum of GDP) reflects the amount of GDP released upon R*⅐G t complex formation. Normalization of the peak areas by the different extinction coefficients of R* and GDP yielded approximately the same values, i.e., equimolar amounts of R* and GDP (see figure legend and Materials and Methods for details). Accordingly, one GDP molecule was released from G t ⅐GDP upon interaction with R*, again consistent with a 1:1 R*⅐G t complex.
Analysis of Gt Activation by Monomeric
Rhodopsin. For G t activation measurements, we used the central fraction of the SEC elution peak, shown above to contain pure monomeric rhodopsin (Fig.  3A) . To quantify the catalytic capacity of monomeric rhodopsin, we determined the initial rate of G t activation by monitoring the intrinsic tryptophan fluorescence change of the G protein ␣-subunit, linked to GTP␥S uptake (Fig. 5A ). We first measured the activation rate [expressed as activated G t molecules (G t *) per second] as a function of rhodopsin concentration (R* ϭ 0-3.0 nM; Fig. 5A Inset) . The found linear dependence allowed the measured activation rates to be normalized to R*. To obtain the maximum velocity (V max ) of the reaction, we titrated the fluorescence changes with G protein up to a concentration of 12 M G t . The highest activation rate measured was Ϸ40 G t */R*⅐s (Fig.  5B ). This is a lower limit because at higher G t concentrations the rate decreased. Titration curves significantly deviate from the simple Michaelis-Menten type of hyperbolic curve, because of subunit dissociation at low G t concentration and inhibition of R*/G t interaction by the detergent (Fig. 5B ). G t interacts with detergent micelles because of its hydrophobic modifications, i.e., myristoylation of the ␣-subunit and farnesylation of the ␥-subunit (25 
, which is close to the diffusion limit expected for the encounter of two proteins in solution (26) and shows that the catalytic interaction between monomeric rhodopsin and its G protein is very efficient.
Discussion
Our results show that in DDM detergent solution rhodopsin interacts with its cognate G protein G t in a 1:1 stoichiometry and A B that the rhodopsin monomer also is competent to activate G t with a rate close to the physical limit in solution. The maximum rate in the native membrane still is about one order of magnitude higher than in solution (27, 28) . This finding may be explained by the reduction in translational degrees of freedom in a two-dimensional membrane, which facilitates successful coupling. Fast and immediate docking is enabled by the precise orientation of the G protein to the membrane surface. The membrane anchor of the G protein made up of the myristoyl/ farnesyl modifications at the ␣-and ␥-subunits, respectively (25, 29, 30) , now can play a decisive role in the initial encounter between the proteins. Evidence for a sequential interaction between different binding sites on G t and R*, which includes such a docking process, recently was presented (30, 31) . Computational modeling suggested a single rhodopsin molecule to be sufficient for docking of G t (32, 33) . It remains to be elucidated whether a pairing of rhodopsin in disk membranes further improves the overall speed of catalytic G t activation.
Materials and Methods
Materials. All materials and purified anti-rhodopsin monoclonal antibody rho-1D4 were as described in ref. 34 
Construction of R-mVenus, R-mECFP, and mVenus-mECFP Fusion
Plasmids. The mammalian cell expression vector pMT4 containing a synthetic opsin gene was modified by standard cloning and PCR procedures such that the opsin gene was followed by bases GGATCAACCGGT (the AgeI site is underlined), then followed by the gene corresponding to the monomeric fluorescent proteins mECFP or mVenus and codons corresponding to the amino acid sequence GTETSQVAPA. Rhodopsin's C-terminal sequence ETSQVAPA is recognized by the rho-1D4 antibody used for immunoaffinity purification of the fusion proteins (35 (38) , and A206K [to avoid dimerization (37) ]. The control construct mVenus-mECFP was cloned by replacing the EcoRISalI fragment of R-mECFP with the mVenus gene. The gene product corresponds to a fusion protein of mVenus and mECFP separated by a 20-aa linker sequence. In the plasmid R-mVenus⌬, bases corresponding to the C-terminal amino acid sequence GTETSQVAPA were deleted. All constructs were verified by DNA sequencing.
Expression and Purification of Rhodopsins. Rhodopsin, R-mVenus, R-mECFP, and mVenus-mECFP fusion proteins were expressed in COS-1 cells by using a diethylamino-ethyl (DEAE)-dextran transfection procedure. The cells were harvested 72 h after transfection, and 11-cis-retinal was added to reconstitute rhodopsin (34, 39) . The expressed proteins were purified by using a rho-1D4-Sepharose immunoaffinity matrix as described (34, 39) . All procedures were carried out under dim red light. Briefly, cells were harvested in PBS buffer (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , and 1.5 mM KH 2 PO 4 , pH 7.4) and reconstituted with 11-cis-retinal (30 M final concentration) for 12 h at 6°C. Cells were solubilized in 1% (wt/vol) DDM for 2-4 h at 6°C and then incubated with rho-1D4-Sepharose matrix overnight. For protein purification, the matrix was washed repetitively in a batch procedure using centrifugation to separate matrix and solution. Wash steps were performed twice with 0.03% (wt/vol) DDM in PBS and then once or twice with 0.03% (wt/vol) DDM in 10 mM 1,3-bis[Tris(hydroxymethyl)methylamino]propane (BTP), pH 6.0. Immunoaffinity-purified protein was eluted from the matrix by adding 150 M peptide corresponding to the C-terminal 18 aa of rhodopsin (3-4 h, 6°C). The eluted protein was separated from the matrix by centrifugation.
Preparation of Transducin. G t was prepared from bovine rod outer segments and in most cases was separated into G␣ and G␤␥ subunits by chromatography as described in ref. 27 . G t or its separated subunits (8-15 ml) were incubated with 0.5-ml Con A Sepharose 4B beads (GE Healthcare, Barrington, IL) at 6°C for 1 h to remove traces of rhodopsin. then were dialyzed against buffer A containing 2 mM DTT. Dialyzed G t or G t subunits were concentrated by ultrafiltration using Centricon YM-10 concentrators (Millipore, Billerica, MA) and stored on ice until use. Protein concentration was determined with Bradford reagent. The final G t concentration ranged between 30 and 40 M. To determine the amount of activatable G t , G t was titrated with exact amounts of GTP␥S (250 nM) in the presence of 500 nM R* under constant stirring in a final volume of 700 l (40). GTP␥S concentration was determined by UV/ visible absorption spectroscopy with 253 ϭ 13,700 M Ϫ1 ⅐cm Ϫ1 (41) . All calculated activation rates in this work refer to the amount of activatable G t as determined by GTP␥S titration.
Preparation of Bovine Rhodopsin and SEC. Rod outer segment membranes were prepared as described in ref. 27 . After incubation of the rod outer segment membranes (150 M rhodopsin) with 5 M 11-cis-retinal for 30 min at 4°C, DDM was added to a final concentration of 1.4% (wt/vol) followed by further incubation for 3 h. Unsolubilized material was removed by ultracentrifugation. Solubilized rhodopsin was purified by using the 1D4-immunoaffinity procedure described above (four wash steps). Then, 100 l of purified rhodopsin was applied at a flow rate of 300 l/min and 14-18°C to a Tricorn Superdex 200 300/10 GL column (GE Healthcare) equilibrated with buffer A containing 1 mM DTT and 0.03% (wt/vol) DDM by using a SMART system and SMART Manager software (Amersham Pharmacia/GE Healthcare). The same setup and buffer A containing 0.03% (wt/vol) DDM (with or without 1 mM DTT) was used for SEC of purified rhodopsin with G t at different temperatures (4-12°C). Light activation of rhodopsin was performed as described below.
UV/Visible Spectroscopy. Absorption spectra were taken at 20°C with a Cary 50 Bio UV/visible spectrophotometer (Varian, Palo Alto, CA) with a resolution of 1 or 2 nm. For each sample, absorption spectra between 250 and 650 nm were recorded in the dark and after illumination of the sample for 15 s with orange light with a 150-W fiber-optic light source equipped with a long-pass filter (GG 495; Schott, Elmsford, NY) and a heatprotection filter. Calculation of the A280/A380 Ratio of the R*⅐Gt Complex. For determination of the stoichiometry of R* and G t in the R*⅐G t complex from UV/visible absorption data obtained by SEC, the ratio of the absorption of the protein moiety in the R*⅐G t complex to the retinal chromophore absorption was calculated as follows: ϭ 2⅐42,000/13,700 ϭ 6.13 for a 2:1 (R*:G t ) stoichiometry.
Molar Extinction Coefficients for Analysis of UV/Visible Absorption
A
MALLS.
For mass determination, a combined setup consisting of SEC and subsequent online detection by UV absorption, threeangle static MALLS and differential refractive index measurement was used (48) . SEC was performed with a Tricorn Superdex 200 10/300 GL column (GE Healthcare) connected to an Ä KTA purifier chromatography system (GE Healthcare) equilibrated with buffer A containing 1 mM DTT and 0.005 or 0.03% (wt/vol) DDM, respectively. For MALLS and differential refractive index measurements, a linear coupled miniDAWN Tristar system (Wyatt Technology, Santa Barbara, CA) and a differential refractive index detector (RI-101; Shodex, Kawasaki, Japan), respectively, were used. All calculations were performed with the software ASTRA (Wyatt Technology) on the basis of the detected signals for the UV absorption (280 nm), the refractive index (49) , and three different scattering angles of scattered laser light. Experiments were performed at 4-6°C. Each experiment was repeated at least in triplicate. Under both detergent conditions of SEC, 0.005% or 0.03% (wt/vol) DDM, rhodopsin eluting in the SEC peak fraction was monomeric. For calculation of the molar masses, an extinction coefficient (at 280 nm) of 1,667 ml⅐g Ϫ1 ⅐cm Ϫ1 for rhodopsin and a dn/dc value of 0.133 for DDM (49) was used. Effects of interdetector band broadening between instruments in the online experiment were corrected by using ASTRA software.
Transducin Activation Assay. As a monitor for G t activation, changes in intrinsic fluorescence intensity of the G␣-subunit upon exchange of GDP to GTP␥S were quantified (40) . All measurements were carried out by using a SPEX fluorolog II spectrofluorometer equipped with a 450-W xenon arc lamp. For all activation measurements, settings were ex ϭ 300 nm and em ϭ 345 nm with an integration time of 1 s. G t activation rates were measured with 0-3 nM purified rhodopsin, 200 M GTP␥S, buffer A, 2 mM DTT, and 0.003-0.015% (wt/vol) DDM in a final volume of 80 l (3 ϫ 3 mm cuvette) or 650 l (10 ϫ 4 mm cuvette with stirring bar). All samples were equilibrated at 20°C for 4 min. Reactions were triggered with orange light (Schott GG 495 long-pass filter) after recording basic fluorescence levels for 50 s. After recording the activation at the respective R* concentration, activation of the whole G t pool was achieved by adding 5 nM purified rhodopsin to the reaction. The maximal amplitude of fluorescence after addition of excess rhodopsin accounts for the total amount of G t in the sample. Thus, the change in fluorescence (F/t) translates into activated G t molecules per second. The whole set of experiments was repeated with different G t and rhodopsin preparations.
The initial G t activation rate (v) was obtained by linear regression of the initial rise in fluorescence emission. The fluorescence change was titrated with G t , and the data points were fitted to a Michaelis-Menten type hyperbolic function:
where V max and K m denote the maximum value of v and the Michaelis constant, respectively, and [G␣␤␥] is the effective G t concentration.
[G␣␤␥] was calculated numerically in the fitting procedure by assuming that a fraction of the added G t dissociates into its G␣ and G␤␥ subunits (with a dissociation constant K 1 ) or binds to detergent micelles without rhodopsin (with a dissociation constant K 2 ; see SI Methods). The data points of the titration experiments performed at three different DDM concentrations (0.01%, 0.008%, and 0.006%) were simultaneously fitted with the same set of parameters V max , K 1 , and K 2 but with individual Michaelis constants (K m1 , K m2 , and K m3 ). DDM micelle concentration was set to 1.2 M (0.006% DDM), 1.6 M (0.008% DDM), and 2 M (0.01% DDM).
FRET Experiments. Fluorescence emission spectra between 450-600 nm (excitation at 420 nm) and 520-600 nm (excitation at 510 nm) of fluorescent proteins were recorded at 20°C with a SPEX fluorolog II spectrofluorometer and corrected for the fluorescence emission of the buffer. To determine FRET between mECFP and mVenus, the spectra of 11-cis-retinal-reconstituted purified R-mECFP and copurified R-mECFP/R-mVenus, respectively, were compared. Direct excitation of R-mVenus by the 420-nm excitation beam in the R-mECFP/R-mVenus mixture was accounted for as follows. (i) The emission spectrum of the R-mVenus reference sample (excitation at 420 nm) was scaled to the amount present in the R-mECFP/R-mVenus mixture by comparing maximal mVenus emission at 530 nm (excitation at 510 nm). (ii) The scaled R-mVenus emission spectrum (excitation at 420 nm) then was subtracted from the emission spectrum of the R-mECFP/R-mVenus mixture (excitation at 420 nm). The difference spectrum of the corrected R-mECFP/R-mVenus spectrum and the R-mECFP spectrum (matched to the peak height at 480 nm) yields the emission attributable to FRET. The same procedure was applied to analyze the mVenus-mECFP fusion protein. For the measurement, purified samples were diluted with 2 vol of buffer A containing 2 mM DTT, yielding a final concentration of 0.01% (wt/vol) DDM and 0.75 M protein.
